주식/증권 ➡️ 중립

Nektar outlines REZPEG Phase III timeline with mid-2028 data and 2029 BLA plan

Seeking Alpha - Market News 08/14/2026 03:27:54 AM 73회

원문 기사 보기

관련 뉴스

Pharvaris rises after BofA upgrades to Buy

Evonik gains on report BASF increased offer for Evonik to over €11B

Western Digital in focus as Wall Street defends amid capex concerns

Flagstar Bank stock drops as Q3 provisions, net interest income hit earnings

뉴스 목록으로